Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Omeros (OMER)

Omeros Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMER
DateTimeSourceHeadlineSymbolCompany
01/04/202421:02Business WireOmeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
27/03/202412:30Business WireOmeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024NASDAQ:OMEROmeros Corporation
20/02/202414:00Business WireOmeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
14/02/202411:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMEROmeros Corporation
07/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
01/02/202414:11Business WireOmeros Corporation Announces Additional Royalty Monetization with DRI Healthcare TrustNASDAQ:OMEROmeros Corporation
29/01/202420:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OMEROmeros Corporation
22/11/202301:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
16/11/202302:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
09/11/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
09/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
09/11/202321:02Business WireOmeros Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
06/11/202313:00Business WireOmeros Corporation to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:OMEROmeros Corporation
03/11/202313:05Business WireOmeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
02/11/202313:05Business WireOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingNASDAQ:OMEROmeros Corporation
19/10/202313:30Business WireOmeros Corporation Hires Andreas Grauer M.D. as Chief Medical OfficerNASDAQ:OMEROmeros Corporation
16/10/202321:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
16/10/202312:30Business WireOmeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA NephropathyNASDAQ:OMEROmeros Corporation
27/09/202322:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
27/09/202321:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
27/09/202321:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
20/09/202321:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OMEROmeros Corporation
15/09/202300:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
09/08/202322:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OMEROmeros Corporation
09/08/202313:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
09/08/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
09/08/202313:00Business WireOmeros Corporation Reports Second Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
 Showing the most relevant articles for your search:NASDAQ:OMER